mechanism 1,409 words KG: ent-gene-694200ea
Contents

GBA Therapy in Parkinson's Disease

🔬 Protein Info
Gene Symbolent-gene-694200ea
Chromosome1q21
Lysosomal functionMaintains proper lysosomal degradation capacity
Autophagy regulationSupports macroautophagy and chaperone-mediated autophagy
Calcium homeostasisInfluences lysosomal calcium storage and signaling
Mitochondrial functionAffects mitochondrial quality control mechanisms
Protein homeostasisHelps maintain cellular proteostasis through lysosomal pathways
Earlier onsetAverage onset 5-10 years earlier than idiopathic PD
More rapid progressionFaster cognitive decline and motor progression
Higher prevalence of non-motor symptomsMore frequent cognitive impairment, psychosis, and autonomic dysfunction
Increased Lewy body pathologyMore widespread alpha-synuclein pathology
KG Connections4 knowledge graph edges
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (32)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.38
Smartphone-Detected Motor Variability Correction
Score: 0.74
Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.51
Enteric Nervous System Prion-Like Propagation Blockade
Score: 0.48
Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.95
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.78
CYP46A1 Overexpression Gene Therapy
Score: 0.77
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.76
Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.74
PARP1 Inhibition Therapy
Score: 0.74
Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.71
Orexin-Microglia Modulation Therapy
Score: 0.71
TET2-Mediated Demethylation Rejuvenation Therapy
Score: 0.71
Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.70
Lysosomal Calcium Channel Modulation Therapy
Score: 0.70
Complement C1q Mimetic Decoy Therapy
Score: 0.69
Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th
Score: 0.69
Ganglioside Rebalancing Therapy
Score: 0.69
Hypocretin-Neurogenesis Coupling Therapy
Score: 0.69
R-Loop Resolution Enhancement Therapy
Score: 0.68
pg 1/2Next →

Related Analyses (30)

Astrocyte Reactivity Subtypes in Neurodegeneration
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived

Related Experiments (30)

Validate Mitochondria-Lysosome Contact Site Dysfunction in P
validation · proposed · Score: 0.40
Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
clinical · proposed · Score: 0.40
Prodromal Parkinson's Disease Biomarker Development — Early
clinical · proposed · Score: 0.40
DLB Treatment Response Biomarkers — Predicting Cholinesteras
clinical · proposed · Score: 0.40
Synaptic Vesicle Trafficking Dysfunction Validation in Parki
clinical · proposed · Score: 0.40

Knowledge Graph (4 edges)

ent-gene-694200ea data_in benchmark_ot_ad_answer_key:GBA
benchmark_ot_ad_answer_key:GBA data_in ent-gene-694200ea
ent-gene-694200ea participates_in_pathway R-HSA-9840310
ent-gene-694200ea participates_in_pathway R-HSA-390471

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.